[Prospective randomized multicenter phase IIB study in patients with mumps orchitis].
Erpenbach
K
K
Sanitätszentrum Kerpen.
Miller
K
K
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D009107:Mumps / Q000628:therapy*; D009920:Orchitis / Q000628:therapy*; D011446:Prospective Studies; D011994:Recombinant Proteins
D000893:Anti-Inflammatory Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Prospektiv randomisierte Multizentrische Phase-IIB-Prüfung bei Patienten mit Mumpsorchitis.